Sat.Dec 11, 2021 - Fri.Dec 17, 2021

article thumbnail

Pfizer buys immuno-inflammatory firm Arena Pharmaceuticals for $6.7b

Outsourcing Pharma

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.

article thumbnail

Insurtech platform HealthCare.com banks $180M, boosts valuation to $1B

Fierce Healthcare

Insurtech platform HealthCare.com banks $180M, boosts valuation to $1B. rtorrence. Mon, 12/13/2021 - 15:15.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

From patient engagement to patient centricity

pharmaphorum

Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. But the difference between them is not like the choice between “agreeing” and “aligning” or “getting together later” and “taking this offline.” Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery.

article thumbnail

2022 Predictions From the Front-Lines of Pharma Digital Advertising

Pharma Marketing Network

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. In this article, R.J. Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Insilico Medicine launches trial for AI-discovered drug

Outsourcing Pharma

The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.

141
141
article thumbnail

Oracle in talks to buy Cerner in potential $30B deal: WSJ

Fierce Healthcare

Oracle in talks to buy Cerner in potential $30B deal: WSJ. hlandi. Fri, 12/17/2021 - 07:56.

Cerner 139

More Trending

article thumbnail

Getting Creative with Sustainability | How Pharma Engages

Pharma Marketing Network

Big pharma has compelling reasons to change the way business gets done. The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. Leaders are hard at work focusing their efforts on how to use sustainability as a platform for innovation. Step one is to assess your corporate social responsibility (CSR) policies and ensure actions are integrated across the organization.

article thumbnail

New inhaled SARS-CoV-2 antibody treatment set to enter clinical trials

Outsourcing Pharma

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.

140
140
article thumbnail

Hospitals across the country running out of beds, reducing surgeries amid latest COVID surge

Fierce Healthcare

Hospitals across the country running out of beds, reducing surgeries amid latest COVID surge. hlandi. Sun, 12/12/2021 - 22:15.

Hospitals 138
article thumbnail

Biogen’s Alzheimer’s drug Aduhelm is rejected by EU advisors

pharmaphorum

The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced by the data submitted for the drug. The companies had already indicated that the CHMP looked likely to turn down their marketing application for Aduhelm (aducanumab), but the decision nevertheless is a heavy blow, coming as take-up of the drug has pretty much stalled in the US.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharma Marketing’s Data-Driven Omnichannel Future: Four Interconnected Themes from Reuters Pharma Marketing USA 2021

Pharma Marketing Network

#1: Omnichannel engagement is the key to creating personalized customer experiences and relevancy, but it remains something of a holy grail within the pharmaceutical industry. Across several sessions at this year’s Reuters Pharma Marketing USA, leading marketers discussed why it’s been such an uphill struggle and shared possible solutions. Traditionally, pharmaceutical companies have been siloed to a degree that would be unthinkable in most other industries.

article thumbnail

Michael J. Fox Foundation significantly expands Parkinson’s study

Outsourcing Pharma

The Parkinsonâs Progression Markers Initiative, built using Evidation Healthâs research platform, aims to triple enrollment and recruit online participants.

126
126
article thumbnail

KFF poll: Half of US adults avoided care in the past year due to costs

Fierce Healthcare

KFF poll: Half of US adults avoided care in the past year due to costs. agliadkovskaya. Thu, 12/16/2021 - 13:51.

130
130
article thumbnail

FDA sets April date for verdict on Incyte’s vitiligo drug

pharmaphorum

Incyte could be a few month away from a second FDA approval for its Opzelura cream that would make it the first medical treatment to re-pigment the skin of people with vitiligo. The FDA has kicked off a priority review of Opzelura (ruxolitinib), a JAK1/JAK2 inhibitor it approved to treat atopic dermatitis in September, and aims to decide on the vitiligo indication by 18 April next year.

FDA 111
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Prescription Drugs and Their Role in D.U.I. Incidents

Pharma Mirror

Impaired driving due to prescription medication is often given less attention than driving under the influence of illegal drugs. Yet, prescription drugs are just as dangerous, if not more dangerous, because many people are either not aware of the drug’s influence on their driving or assume prescribed medication is “safe.” Some medication, however, significantly increases the risk of car crashes.

52
article thumbnail

Abbott, Howard University join to boost research diversity

Outsourcing Pharma

The pharma firm has gifted $1m USD to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.

102
102
article thumbnail

Federal appeals court revives Biden's vaccine mandate for health workers in 26 states

Fierce Healthcare

Federal appeals court revives Biden's vaccine mandate for health workers in 26 states. hlandi. Thu, 12/16/2021 - 16:52.

Vaccines 128
article thumbnail

As Omicron cases rise, EMA backs early use of Pfizer’s Paxlovid

pharmaphorum

The EMA’s human medicines committee has said that EU member states can start to offer Pfizer’s oral antiviral Paxlovid as a treatment for people with COVID-19 outside hospital, ahead of a formal approval for the drug. The decision comes amid rising rates of infection and deaths due to COVID-19 across the EU, and with 529 new cases of the worrisome Omicron variant reported in member states yesterday, taking the total number to 3,158.

Hospitals 105
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Employee Spotlight: Paula Styer Pharmacy Technician

indispensable health

An Interview With Paula Styer, Licensed Pharmacy Technician (LPhT). What Is Your Name and Job Title? Well, my name is Paula Styler and I am a pharmacy technician. I have been a pharmacy technician since 2008. When Did You Become Interested in Pharmacy? I had been working in photography for a very long time, and the studio I worked for closed. I was unemployed for about a year and a half to two years.

article thumbnail

Most oncologists think RWD vital to advancing cancer research: COTA

Outsourcing Pharma

The company has released a survey of cancer doctors; 83% of those polled believe real-world data is crucial to accelerating cancer research and treatment.

98
article thumbnail

HHS to distribute $9B in COVID-19 relief funds to smaller providers this week

Fierce Healthcare

HHS to distribute $9B in COVID-19 relief funds to smaller providers this week. rking. Tue, 12/14/2021 - 11:31.

128
128
article thumbnail

Judge rejects Purdue opioid settlement over Sackler family immunity

pharmaphorum

A judge in the US has rejected the bankruptcy plan proposed by Purdue Pharma to settle legal action over its role in the opioid crisis , because of the protection from civil litigation it includes for the Sackler family that owns the drugmaker. Judge Colleen McMahon has thrown out the plan in a New York court, in a move that would remove the shield handed to the Sackers in return for a $4.5 billion payout to projects intended to support victims of the opioid crisis over a nine-year period.

article thumbnail

Don’t Forget Referral Capture Strategies

Turnkey Pharmacy Solutions

Written By: Rich Bucher While implementing a referral capture strategy can potentially lead to significant 340B savings for your 340B covered entity (CE), it is important to remember that you, the CE, remain responsible for ensuring full compliance. Managing a fully compliant and cost-effective referral process will require diligence and resources, despite what some third-party.

52
article thumbnail

ASH 2021 sees Novartis launch a 'next-generation' CAR-T platform

Outsourcing Pharma

Novartis has introduced its T-Charge platform at ASH 2021, which it says will serve as the foundation for various new investigational CAR-T cell therapies in its pipeline.

98
article thumbnail

CMS actuaries: Healthcare expenditures spiked 9.7% in 2020 amid COVID-19 response

Fierce Healthcare

CMS actuaries: Healthcare expenditures spiked 9.7% in 2020 amid COVID-19 response. pminemyer. Wed, 12/15/2021 - 16:28.

128
128
article thumbnail

BMS’ Orencia gets FDA nod for GvHD thanks to real-world data

pharmaphorum

Bristol-Myers Squibb’s rheumatoid arthritis drug Orencia has been approved by the FDA to prevent graft versus host disease (GvHD), a serious complication of haematopoietic stem cell transplant (HSCT) used to treat leukaemias and other blood cancers. Orencia (abatacept) becomes the first drug to be approved to prevent GvHD , a condition in which donor immune cells attack tissues in the patient receiving an HSCT, commonly known as a bone marrow transplant.

FDA 105
article thumbnail

Site Management Organizations (SMOs): A Trending Term in the Clinical Trial Domain

Roots Analysis

Innovators in the pharmaceutical industry are constantly developing ways to improve the process of conducting clinical trials and managing research sites. Amidst other alternatives, outsourcing various trial operations to a specialized service provider, such as site management organizations (SMOs), has emerged as a viable option for various developers.

52
article thumbnail

COVID-19 updates, actions, and advice from the FDA

Outsourcing Pharma

The US agency continues to work with industry professionals on vaccines and treatments for the virus, and to wrestle with current and emerging variants.

article thumbnail

Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger

Fierce Healthcare

Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger. pminemyer. Wed, 12/15/2021 - 13:27.

Insurance 125
article thumbnail

2021: the year mRNA therapeutics came of age

pharmaphorum

It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. One of its other scientific legacies was the specific development and approval of mRNA vaccines, the first in that drug class on the market.

Vaccines 105
article thumbnail

IMPACT OF AT-HOME BLOOD COLLECTION AND MICRO SAMPLING DEVICES

Roots Analysis

Earlier, approaches used for blood collection were invasive, time consuming and needed a healthcare expert. However, in recent years, the methods for blood collection are evolving at a rapid pace. According to research study, 69% of participant were found to take part more likely in clinical trials, if they are able to provide self-collected sample (at-home blood collection).

52
article thumbnail

Industry insights: obstacles, positives, and looking ahead

Outsourcing Pharma

Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.

81
article thumbnail

CMS: Insurers paid out $2B in medical loss ratio rebates for 2020 claims

Fierce Healthcare

CMS: Insurers paid out $2B in medical loss ratio rebates for 2020 claims. rking. Fri, 12/17/2021 - 16:06.

Insurance 122